Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
Medication-related osteonecrosis of the jaw (MRONJ) is a major problem that can occur in people taking certain medications such bisphosphonates and denosumab. It can be used to treat osteoporosis or cancer. Bisphosphonate exposure, dental diseases and procedures, age, sex, anatomical factors, medica...
Saved in:
Main Authors: | Raed AlRowis (Author), Abdulmalik Aldawood (Author), Mohammed AlOtaibi (Author), Essam Alnasser (Author), Ibrahim AlSaif (Author), Abdullah Aljaber (Author), Zuhair Natto (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Yong-Dae Kwon, et al.
Published: (2016) -
Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
by: Britt-Isabelle Berg, et al.
Published: (2016) -
Panoramic Radiography Features of Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Rossana Izzetti, et al.
Published: (2023) -
New groups of drugs suspected in the medication-related osteonecrosis of the jaws (MRONJ)
by: Mel Mupparapu, et al.
Published: (2017) -
Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
by: Ran Yan, et al.
Published: (2022)